Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | TPIV100 |
Trade Name | |
Synonyms | TPIV-100|TPIV 100 |
Drug Descriptions |
TPIV100 is a ERBB2 (HER2) vaccine derived from four peptides from ERBB2 (HER2) (NCI Thesaurus). |
DrugClasses | HER2 (ERBB2) Vaccine 14 |
CAS Registry Number | NA |
NCIT ID | C173525 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Ado-trastuzumab emtansine + Sargramostim + TPIV100 | Ado-trastuzumab emtansine Sargramostim TPIV100 | 0 | 1 |
Sargramostim + TPIV100 + Trastuzumab | Sargramostim TPIV100 Trastuzumab | 0 | 0 |
TPIV100 | TPIV100 | 0 | 0 |